Dipromon

Multimodular biomarker analysis workflow for diagnosis, prognosis and monitoring of drug treatment response in bladder cancer

Publications

. Validation of a protein panel for the noninvasive detection of recurrent non-muscle invasive bladder cancer.
Biomarkers, (22), 7, 674–681, https://doi.org/10.1080/1354750X.2016.1276628, 2016.

Project

. Predictive Biomarkers for Linking Disease Pathology and Drug Effect.
Current pharmaceutical design, (23), 1, 29–54, https://doi.org/10.2174/1381612822666161006153639, 2016.

Project

. Disease map-based biomarker selection and pre-validation for bladder cancer diagnostic.
Biomarkers, (20), 5, 328–337, https://doi.org/10.3109/1354750X.2015.1068867, 2015.

Project

. Protein interactome of muscle invasive bladder cancer.
PloS one, (10), 1, e0116404, https://doi.org/10.1371/journal.pone.0116404, 2015.

Project